Gene · 6528
Papers4,585
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 4,585
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Iodine Intake and Testosterone. | JAMA Netw Open | 2023 | 38117501 | PubTator, text mining | PubMed |
| Mendelian randomization suggests a causal relationship between gut dysbiosis and thyroid cancer. | Front Cell Infect Microbiol | 2023 | 38106470 | PubTator, text mining | PubMed |
| Results of neonatal screening for congenital hypothyroidism and hyperphenylalaninemia in Zhejiang province from 1999 to 2022. | Zhejiang Da Xue Xue Bao Yi Xue Ban | 2023 | 38105685 | PubTator, text mining | PubMed |
| Editorial: [Application of stem cells in the treatment of myocardial infarction]. | Front Cardiovasc Med | 2023 | 38094117 | PubTator, text mining | PubMed |
| Current Molecular and Clinical Landscape of ATRT - The Link to Future Therapies. | Cancer Manag Res | 2023 | 38089834 | PubTator, text mining | PubMed |
| Exploring the clinical utility of angioinvasion markers in papillary thyroid cancer: a literature review. | Front Endocrinol (Lausanne) | 2023 | 38089632 | PubTator, text mining | PubMed |
| Natural Product Synthesis: The Endless Quest for Unreachable Perfection. | ACS Org Inorg Au | 2023 | 38075446 | PubTator, text mining | PubMed |
| Gaining insights into virotherapy with canine models. | Mol Ther Oncolytics | 2023 | 38075242 | PubTator, text mining | PubMed |
| Cross species extrapolation of the disruption of thyroid hormone synthesis by oxyfluorfen using in vitro data, physiologically based pharmacokinetic (PBPK), and thyroid hormone kinetics models. | Curr Res Toxicol | 2023 | 38074188 | PubTator, text mining | PubMed |
| Early Functional Outcomes in Low Back Pain Subjects with a Novel Interspinous Fusion Device: REFINE Study 6-Month Results. | J Pain Res | 2023 | 38058981 | PubTator, text mining | PubMed |
| Incidentally Detected Metachronous Malignancy in Patients of Papillary Carcinoma of Thyroid Posthigh-Dose Radioiodine Therapy. | Indian J Nucl Med | 2023 | 38046960 | PubTator, text mining | PubMed |
| False-Positive Radioiodine Uptake in the Cervix in a Patient with Thyroid Cancer. | Indian J Nucl Med | 2023 | 38046958 | PubTator, text mining | PubMed |
| CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case study. | Ther Adv Med Oncol | 2023 | 38028143 | PubTator, text mining | PubMed |
A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses. | Front Immunol | 2023 | 38022659 | PubTator, text mining | PubMed |
| BRAF K601E Mutation in Oncocytic Carcinoma of the Thyroid: A Case Report and Literature Review. | J Clin Med | 2023 | 38002585 | PubTator, text mining | PubMed |
| The Effects of Deregulated Ribosomal Biogenesis in Cancer. | Biomolecules | 2023 | 38002277 | PubTator, text mining | PubMed |
| MicroRNA-21 promotes head and neck squamous cell carcinoma (HNSCC) induced transition of bone marrow mesenchymal stem cells to cancer-associated fibroblasts. | BMC Cancer | 2023 | 37993769 | PubTator, text mining | PubMed |
| Autonomously functioning thyroid nodules present intermediate malignancy risk according to European Thyroid Imaging Reporting and Data System (EU-TIRADS) and yield indeterminate cytology results. | Eur Thyroid J | 2023 | 37992294 | PubTator, text mining | PubMed |
| Divergence in the Saccharomyces Species' Heat Shock Response Is Indicative of Their Thermal Tolerance. | Genome Biol Evol | 2023 | 37972247 | PubTator, text mining | PubMed |
| Substrate self-derived porous rod-like NiS/Ni9S8/NF heterostructures as efficient bifunctional electrocatalysts for overall water splitting. | Dalton Trans | 2023 | 37971051 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6528/papers?page=19